 | • レポートコード：MRC-IM30702 • 出版社/出版日：IMARC / 2023年2月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2022年987.1億ドルであった世界の性感染症（STD）診断市場規模が2028年には1,359.4億ドルに達し、予測期間中（2023年-2028年）、年平均5.39％成長すると予測しています。当調査資料では、性感染症（STD）診断の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、その他）分析、デバイス別（研究用デバイス、PoCデバイス）分析、エンドユーザー別（臨床検査、ポイントオブ ケア (PoC) 検査）分析、地域別（北米、アジア、欧州、中南米、中東/アフリカ）分析、要因・制約・機会、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、Abbott Laboratories、Becton Dickinson and Company、BioMérieux SA、Bio-Rad Laboratories Inc.、Cepheid (Danaher Corporation)、F. Hoffmann-La Roche AG、Hologic Inc.、Qiagen N.V.、Quidel Corporation、Siemens Healthineers AG (Siemens AG)などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の性感染症（STD）診断市場規模：種類別 - クラミジア検査の市場規模 - 梅毒検査の市場規模 - 淋病検査の市場規模 - 単純ヘルペスウイルス検査の市場規模 - その他種類の市場規模 ・世界の性感染症（STD）診断市場規模：デバイス別 - 研究用デバイスの市場規模 - PoCデバイスの市場規模 ・世界の性感染症（STD）診断市場規模：エンドユーザー別 - 臨床検査における市場規模 - ポイントオブ ケア (PoC) 検査における市場規模 ・世界の性感染症（STD）診断市場規模：地域別 - 北米の性感染症（STD）診断市場規模 - アジアの性感染症（STD）診断市場規模 - 欧州の性感染症（STD）診断市場規模 - 中南米の性感染症（STD）診断市場規模 - 中東/アフリカの性感染症（STD）診断市場規模 ・要因・制約・機会 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global sexually transmitted disease (STD) diagnostics market size reached US$ 98.71 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 135.94 Billion by 2028, exhibiting a growth rate (CAGR) of 5.39% during 2023-2028. The rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits represent some of the key factors driving the market.
Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.
Sexually Transmitted Disease (STD) Diagnostics Market Trends:
The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth. Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) – based mobile applications that can diagnose STDs by analyzing digital images of an individual’s private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global sexually transmitted disease (STD) diagnostics market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, device type, and end user.
Type Insights:
Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing
Others
The report has provided a detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the type. This includes chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus , chancroid testing, and others. According to the report, chlamydia testing represented the largest segment.
Device Type Insights:
Laboratory Devices
Thermal Cycler – PCR
Lateral Flow Readers
Flow Cytometers
Absorbance Microplate Reader – Enzyme Linked Immunosorbent Assay (ELISA)
Others
Point of Care (PoC) Devices
Phone Chips (Microfluidics + ICT)
Portable/Bench Top/Rapid Diagnostic Kits
A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the device type has also been provided in the report. This includes laboratory devices (thermal cycler – PCR, lateral flow readers, flow cytometers, absorbance microplate reader – enzyme linked immunosorbent assay (ELISA), and others) and point of care (PoC) devices (phone chips (microfluidic + ICT) and portable/bench top/rapid diagnostic kits). According to the report, laboratory devices accounted for the largest market share.
End User Insights:
Laboratory Testing
Point of Care (PoC) Testing
A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the end user has also been provided in the report. This includes laboratory and point of care (PoC) testing. According to the report, laboratory testing accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
What are the key regional markets?
Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
What is the breakup of the market based on the type?
Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
What is the breakup of the market based on the device type?
Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
What is the breakup of the market based on end user?
Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Sexually Transmitted Disease (STD) Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Chlamydia Testing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Syphilis Testing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Gonorrhea Testing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Herpes Simplex Virus Testing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Human Papilloma Virus Testing
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Human Immunodeficiency Virus Testing
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Chancroid Testing
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Device Type
7.1 Laboratory Devices
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Thermal Cyclers – PCR
7.1.2.2 Lateral Flow Readers
7.1.2.3 Flow Cytometers
7.1.2.4 Absorbance Microplate Reader – Enzyme Linked Immunosorbent Assay (ELISA)
7.1.2.5 Others
7.1.3 Market Forecast
7.2 Point of Care (PoC) Devices
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Phone Chips (Microfluidics + ICT)
7.2.2.2 Portable/Bench Top/Rapid Diagnostic Kits
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Laboratory Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Point of Care Testing
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 BioMérieux SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bio-Rad Laboratories Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cepheid (Danaher Corporation)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Hologic Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Qiagen N.V.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Quidel Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Siemens Healthineers AG (Siemens AG)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: Sexually Transmitted Disease Diagnostics Market: Major Drivers and ChallengesFigure 2: Global: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Type (in %), 2022
Figure 5: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Device Type (in %), 2022
Figure 6: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by End User (in %), 2022
Figure 7: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Region (in %), 2022
Figure 8: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Breakup by Country (in %), 2022
Figure 80: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Sexually Transmitted Disease Diagnostics Industry: Drivers, Restraints, and Opportunities
Figure 82: Global: Sexually Transmitted Disease Diagnostics Industry: Value Chain Analysis
Figure 83: Global: Sexually Transmitted Disease Diagnostics Industry: Porter's Five Forces Analysis